- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06271135
Assessing the Quality of Life of Patients With Rosacea
February 14, 2024 updated by: Medical University of Bialystok
The study population consisted of 160 patients (123 women and 37 men) with rosacea, who agreed to participate in this study.
Patients were qualified for the study among people visiting the cosmetic studio in Choroszcz in the period from June 2017 to November 2018, based on the diagnosis of a dermatologist and cosmetologist.
The cosmetic intervention was performed using CAPILLARY REPAIR SERUM (30ml).
Study participants completed self-reported questionnaire and standardized questionnaires.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Białystok, Poland, 15-089
- Medical University of Bialystok
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- the inclusion criteria were: age ≥ 30 years,
- diagnosis of rosacea according to the criteria of the National Rosacea Society Expert Committee (NRSEC) from 2019,
- tolerance to the ingredients of the preparation used in the cosmetic intervention,
- lack of pregnancy and lactation,
- completion of a survey,
- signed informed consent
Exclusion Criteria:
- age < 30 years,
- patients with other facial skin diseases (e.g. acne, psoriasis, eczema),
- intolerance to the ingredients of the preparation used in the cosmetic treatment,
- patients with neuropsychiatric diseases, pregnancy, lactation,
- patients who did not sign informed consent to participate in the study
- did not complete the survey questionnaire.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Participants with rosacea
|
Cosmetic procedures were performed on a group of patients after a cosmetic interview containing questions about contraindications to the procedure.
The treatment was performed 3-times at 2-week intervals and consisted of cavitation peeling and sonophore-sis with an antioxidant preparation dedicated to vascular skin.
The F-808 Skin Scrubber device was used for the treatment.
After a month, the procedure was repeated.
The stages of a cosmetologist's procedure during a cosmetic intervention were as follows: 1. make-up removal; 2. skin diagnostics, exclusion of contraindications, discussion of the procedure; 3. cavitation peeling - gentle skin cleansing using ultrasound; 4. applying an antioxidant cosmetic mixture (composition: rutin, horse chestnut and arnica extract, acerola, vitamin C, moisturizing complex of algae); 5. performing sonophoresis treatment; 6. applying the cream at the end; 7. discussion of indications for further care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Elements influenced on quality of life of participants with rosacea
Time Frame: 17 months
|
The aim of the study was to assess whether antioxidant cosmetic procedures and selected lifestyle elements, especially dietary antioxidants have a significant impact on the quality of life of patients with rosacea.
|
17 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported questionnaire
Time Frame: 17 months
|
Author's questionnaire containing questions on sociodemographic status, anthropometic data, health behaviors, lifestyle, and information on rosacea.
|
17 months
|
|
Dietary Questionnaire
Time Frame: 17 months
|
Energy of diet and nutrients intake were assessed using 3-day 24-h dietary recalls (two randomly selected weekdays and one weekend day) and computer program Diet 6.0.
|
17 months
|
|
The Physical Activity Questionnaire
Time Frame: 17 months
|
The physical activity was assessed by a short version of the International Physical Activity Questionnaire (IPAQ).
|
17 months
|
|
DLQI (Dermatology Life Quality Index)
Time Frame: 17 months
|
The assessment of quality of life in rosacea was carried out using the Polish version of standardized questionnaire DLQI (Dermatology Life Quality Index).
|
17 months
|
|
SWLS (Satisfaction With Life Scale)
Time Frame: 17 months
|
The assessment of satisfaction with life in patients with rosacea was carried out using the Polish version of standardized questionnaire SWLS (Satisfaction With Life Scale).
|
17 months
|
|
BDI (Beck Depression Inventory)
Time Frame: 17 months
|
The assessment of depression in patients with rosacea was carried out using the Polish version of standardized questionnaire BDI (Beck Depression Inventory).
|
17 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Małgorzata E Zujko, Dr., Medical Univeristy of Bialystok
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 8, 2017
Primary Completion (Actual)
November 30, 2018
Study Completion (Actual)
November 30, 2018
Study Registration Dates
First Submitted
February 6, 2024
First Submitted That Met QC Criteria
February 14, 2024
First Posted (Estimated)
February 21, 2024
Study Record Updates
Last Update Posted (Estimated)
February 21, 2024
Last Update Submitted That Met QC Criteria
February 14, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LU20170508
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rosacea
-
Amorepacific CorporationCompletedPapulopustular Rosacea | Erythematotelangiectatic RosaceaKorea, Republic of
-
University of California, DavisCompletedRosacea | Ocular Rosacea | Cutaneous RosaceaUnited States
-
bioRASI, LLCCompletedPapulopustular Rosacea | Erythematotelangiectatic RosaceaUnited States
-
Narrows Institute for Biomedical ResearchSun Pharmaceutical Industries LimitedRecruitingPapulopustular Rosacea | Papular-pustular Rosacea | Papulopustular Rosacea (PPR)United States
-
Actavis Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Bionou Research, S.L.CompletedRosacea | Rosacea, Papulopustular | Rosacea Papular TypeSpain
-
Galderma R&DCompleted
-
University of MiamiCynosureLutronicRecruitingRosacea, Papulopustular | Rosacea, ErythematotelangiectaticUnited States
-
The Fourth Affiliated Hospital of Zhejiang University...Recruiting
-
Cutera Inc.CompletedPapulopustular Rosacea | Erythematotelangiectatic RosaceaUnited States
Clinical Trials on CAPILLARY REPAIR SERUM 30ml
-
Boehringer IngelheimTerminatedChronic Kidney DiseaseUnited States, Germany, Spain, Hungary
-
Tasso Inc.American Research LabsRecruiting
-
Goldman, Butterwick, Fitzpatrick and GroffBabor AmericasNot yet recruitingSkin Aging | Facial Wrinkles
-
Innovative MedicalTerminated
-
Sun Pharmaceutical Industries LimitedActive, not recruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain
-
Hannover Medical SchoolTerminatedDepression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic DisordersGermany